King begins hostile takeover proceedings with Alpharma - Brain Markison, King’s ceo, is disappointed that Dean Mitchell, Alpharma’s ceo, hasn’t responded to his initial offer $1.4 billion offer, which …
Pharma News 8_1
Who needs exercise? Maybe we can get the benefits in a pill! - That dream, cherished by millions of sedentary couch potatoes, just got a little bit closer. Today, researchers are reporting that an …
Pharma News 3_1
Wyeth gets Pristiq approved (a derivative of Effexor) for Major Depressive Disorder. Speaking of anti-depressants, lots of noise being made - and arguments back and forth - about whether they are …